Introduction to the Human Milk Oligosaccharides (HMO) Market 

The Human Milk Oligosaccharides (HMO) Market is gaining strong attention as demand rises for advanced infant nutrition products that closely resemble human breast milk. According to Mordor Intelligence, the Human Milk Oligosaccharides (HMO) Market Size is estimated at USD 338.93 million in 2026 and is projected to reach USD 676.17 million by 2031, growing at a CAGR of 14.82% during the forecast period. 

This steady expansion reflects increasing awareness among parents about early-life nutrition and the importance of gut health and immunity in infants. The Human Milk Oligosaccharides (HMO) Industry is evolving as manufacturers focus on replicating the composition of breast milk using bio-based ingredients. As a result, the Human Milk Oligosaccharides (HMO) Market Growth is closely linked to innovation in infant formula and functional nutrition products. 

Key Trends in the Human Milk Oligosaccharides (HMO) Market 

Rising Demand for Breast Milk-Like Infant Formula 

The growing focus on infant health is a major factor influencing the Human Milk Oligosaccharides (HMO) Market Trends. Parents are increasingly looking for formula products that provide benefits similar to breast milk, especially for immunity and digestive health. This shift is encouraging manufacturers to include HMOs as key functional ingredients. 

Expansion of Premium Infant Nutrition 

The premium infant nutrition segment continues to expand as consumers show willingness to invest in high-quality products. This has increased the Human Milk Oligosaccharides (HMO) Market Share of premium formulas that include multiple HMO blends. Brands are positioning these products as closer alternatives to natural breast milk. 

Clean-Label and Natural Ingredient Preference 

Consumers are paying closer attention to ingredient labels, especially in infant products. The demand for clean-label, natural, and non-GMO ingredients is influencing product development. HMOs, being nature-identical compounds, align well with these expectations and support the overall Human Milk Oligosaccharides (HMO) Market Growth. 

Human Milk Oligosaccharides (HMO) Market Segmentation 

By Product Type 

  • Fucosylated Neutral HMOs 

  • Neutral Core HMOs 

  • Sialylated HMOs 

By Form 

  • Powder 

  • Liquid 

  • Others 

By Application 

  • Infant Formula 

  • Food and Beverage 

  • Dietary Supplements 

  • Pharmaceuticals 

By Geography 

  • North America 

  • Europe 

  • Asia-Pacific 

  • South America 

  • Middle East and Africa 

Key Players in the Human Milk Oligosaccharides (HMO) Market 

  • Nestlé SA 

  • Abbott Laboratories 

  • DSM-Firmenich (including Glycom A/S) 

  • BENEO 

  • Royal FrieslandCampina N.V. 

Conclusion of the Human Milk Oligosaccharides (HMO) Market 

The Human Milk Oligosaccharides (HMO) Market is on a strong growth path, supported by rising awareness of infant health and the increasing demand for high-quality nutrition products. The shift toward functional and science-backed ingredients is creating new opportunities for manufacturers across different regions. 

Looking ahead, the Human Milk Oligosaccharides (HMO) Market Growth is expected to remain steady as applications expand beyond infant nutrition into broader health and wellness categories. This will further enhance the role of HMOs as a key ingredient in modern nutrition solutions.